Literature DB >> 6580949

Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.

A A Forastiere, D R Budman, F Richards, J Aisner, V Weinberg, W C Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6580949

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck.

Authors:  J L Eckenrode; R H Wheeler; A A Forastiere
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogs.

Authors:  R B Natale; R L Cody; M S Simon; R H Wheeler
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.